In the present report, we have investigated the radiosensitizing properties of the Chk1 inhibitor, MK-8776, on human non-small lung cancer (NSCLC) cells and cells derived from head and neck squamous cell carcinomas (HNSCC) and test the p53 dependency of the radiosensitization. Here, TP53 is linked to head and neck squamous cell carcinoma.